Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 2073814)

1.

Retroviral-mediated transfer of interleukin-6 into hematopoietic cells of mice results in a syndrome resembling Castleman's disease.

Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW.

Curr Top Microbiol Immunol. 1990;166:37-41. No abstract available.

PMID:
2073814
2.

Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW.

J Clin Invest. 1990 Aug;86(2):592-9.

3.

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T, et al.

Blood. 1989 Sep;74(4):1360-7.

4.

Expression of human beta globin genes introduced into primitive murine hematopoietic progenitor cells by retrovirus mediated gene transfer.

Bodine DM, Karlsson S, Papayannopoulou T, Nienhuis AW.

Prog Clin Biol Res. 1989;316B:219-33. No abstract available.

PMID:
2694174
5.

Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice.

Screpanti I, Musiani P, Bellavia D, Cappelletti M, Aiello FB, Maroder M, Frati L, Modesti A, Gulino A, Poli V.

J Exp Med. 1996 Oct 1;184(4):1561-6.

6.
7.

Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.

Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y.

Am J Pathol. 1997 Dec;151(6):1517-22.

8.

Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution.

Haneline LS, Li X, Ciccone SL, Hong P, Yang Y, Broxmeyer HE, Lee SH, Orazi A, Srour EF, Clapp DW.

Blood. 2003 Feb 15;101(4):1299-307. Epub 2002 Oct 10.

9.
10.

The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells.

Chertkov JL, Jiang S, Lutton JD, Harrison J, Levere RD, Tiefenthaler M, Abraham NG.

Stem Cells. 1993 May;11(3):218-27.

PMID:
8318909
11.

[Castleman's disease in the pelvic cavity].

Kawamura N, Hayashi T, Abe T, Nakayama J, Mori N, Sekii K, Yoshioka T, Itatani H.

Hinyokika Kiyo. 2007 Feb;53(2):141-4. Japanese.

13.

[Castleman's disease].

Terai C.

Ryoikibetsu Shokogun Shirizu. 2000;(32):511-3. Review. Japanese. No abstract available.

PMID:
11212788
14.

Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture.

Bunting KD, Galipeau J, Topham D, Benaim E, Sorrentino BP.

Ann N Y Acad Sci. 1999 Apr 30;872:125-40; discussion 140-1.

PMID:
10372117
16.

Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

Hawley RG, Hawley TS, Fong AZ, Quinto C, Collins M, Leonard JP, Goldman SJ.

Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10297-302.

17.
18.

Angiofollicular lymphoid hyperplasia (Castleman's disease) in two mice treated with polyoma virus or urethane.

Williams AO, Banks PM, Liebelt AG, Stewart HL, Saffiotti U.

Toxicol Pathol. 1993;21(1):26-34.

19.

Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder.

Wong PM, Chung SW, Dunbar CE, Bodine DM, Ruscetti S, Nienhuis AW.

Mol Cell Biol. 1989 Feb;9(2):798-808.

20.

Does IL-6 mediate renal manifestations of Castleman's disease?

Fujigaki Y, Hishida A.

Intern Med. 2002 Dec;41(12):1086-7. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk